Richard Bruggeman

27.8k total citations
243 papers, 5.7k citations indexed

About

Richard Bruggeman is a scholar working on Psychiatry and Mental health, Clinical Psychology and Cognitive Neuroscience. According to data from OpenAlex, Richard Bruggeman has authored 243 papers receiving a total of 5.7k indexed citations (citations by other indexed papers that have themselves been cited), including 143 papers in Psychiatry and Mental health, 54 papers in Clinical Psychology and 34 papers in Cognitive Neuroscience. Recurrent topics in Richard Bruggeman's work include Schizophrenia research and treatment (127 papers), Bipolar Disorder and Treatment (32 papers) and Mental Health Research Topics (25 papers). Richard Bruggeman is often cited by papers focused on Schizophrenia research and treatment (127 papers), Bipolar Disorder and Treatment (32 papers) and Mental Health Research Topics (25 papers). Richard Bruggeman collaborates with scholars based in Netherlands, United States and United Kingdom. Richard Bruggeman's co-authors include Henderikus Knegtering, André Alemán, Stynke Castelein, Jim van Os, Lieuwe de Haan, Durk Wiersma, Wiepke Cahn, C. J. Slooff, Chris van der Linden and Edith J. Liemburg and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Richard Bruggeman

228 papers receiving 5.5k citations

Peers

Countries citing papers authored by Richard Bruggeman

Since Specialization

Citations

This map shows the geographic impact of Richard Bruggeman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Bruggeman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Bruggeman more than expected).

Fields of papers citing papers by Richard Bruggeman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Bruggeman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Bruggeman. The network helps show where Richard Bruggeman may publish in the future.

Co-authorship network of co-authors of Richard Bruggeman

This figure shows the co-authorship network connecting the top 25 collaborators of Richard Bruggeman. A scholar is included among the top collaborators of Richard Bruggeman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Bruggeman. Richard Bruggeman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Cognitive behavioral therapy for psychosis: a cost-effectiveness study using the EPiSODe model 2025 ·European Psychiatry ·(unknown), (unknown), Wim Veling, Ellen Visser, Jochen O. Mierau, Talitha Feenstra, Richard Bruggeman	0
2	Shaping tomorrow’s support: baseline clinical characteristics predict later social functioning and quality of life in schizophrenia spectrum disorder 2024 ·Social Psychiatry and Psychiatric Epidemiology ·(unknown), (unknown), Tesfa Dejenie Habtewold, Edith J. Liemburg, Richard Bruggeman, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	0
3	Spirituality as a Therapeutic Approach for Severe Mental Illness: Insights from Neural Networks 2024 ·Religions ·Henderikus Knegtering, Richard Bruggeman, (unknown)	4
4	Six-year trajectories and associated factors of positive and negative symptoms in schizophrenia patients, siblings, and controls: Genetic Risk and Outcome of Psychosis (GROUP) study 2023 ·Scientific Reports ·Tesfa Dejenie Habtewold, (unknown), Edith J. Liemburg, (unknown), Md. Atiqul Islam, H. Marike Boezen, (unknown), (unknown), Thérèse van Amelsvoort, Agna A. Bartels‐Velthuis, Lieuwe de Haan, Frederike Schirmbeck, Claudia J.P. Simons, Jim van Os, Richard Bruggeman, (unknown)	9
5	Life years lost for users of specialized mental healthcare 2023 ·Acta Psychiatrica Scandinavica ·(unknown), Jochen O. Mierau, Ellen Visser, Richard Bruggeman, Talitha Feenstra	1
6	Age-Related Social Cognitive Performance in Individuals With Psychotic Disorders and Their First-Degree Relatives 2023 ·Schizophrenia Bulletin ·Eva Velthorst, (unknown), (unknown), Behrooz Z. Alizadeh, Thérèse van Amelsvoort, Agna A. Bartels‐Velthuis, Richard Bruggeman, Wiepke Cahn, Lieuwe de Haan, Frederike Schirmbeck, Claudia J.P. Simons, Jim van Os, Anne‐Kathrin Fett	4
7	Understanding Lifelong Factors and Prediction Models of Social Functioning After Psychosis Onset Using the Large-Scale GROUP Cohort Study 2023 ·Schizophrenia Bulletin ·(unknown), Tesfa Dejenie Habtewold, Edith J. Liemburg, Lisette van der Meer, Richard Bruggeman, Behrooz Z. Alizadeh, (unknown), (unknown), Thérèse van Amelsvoort, Agna A. Bartels‐Velthuis, Lieuwe de Haan, Frederike Schirmbeck, Claudia J.P. Simons, Jim van Os	5
8	Personal recovery suits us all: A study in patients with non-affective psychosis, unaffected siblings and healthy controls 2023 ·Schizophrenia Research ·(unknown), (unknown), Astrid Vellinga, Lian van der Krieke, Stynke Castelein, Thérèse van Amelsvoort, Agna A. Bartels‐Velthuis, Richard Bruggeman, Wiepke Cahn, Claudia J.P. Simons, Jim van Os, Lieuwe de Haan, Frederike Schirmbeck	7
9	ARAS recent onset acute phase psychosis survey, a prospective observational cohort of first episode psychosis in Iran—the cohort profile 2022 ·Schizophrenia ·Sara Farhang, (unknown), Rosa Alikhani, (unknown), Shahrokh Amiri, (unknown), (unknown), Ayyoub Malek, (unknown), Fatemeh Ranjbar, Ali Fakhari, (unknown), (unknown), (unknown), (unknown), Behrooz Z. Alizadeh, Richard Bruggeman, Wim Veling	1
10	A systematic review and narrative synthesis of data-driven studies in schizophrenia symptoms and cognitive deficits 2020 ·Translational Psychiatry ·Tesfa Dejenie Habtewold, (unknown), Edith J. Liemburg, Grigory Sidorenkov, H. Marike Boezen, Richard Bruggeman, Behrooz Z. Alizadeh	63
11	The impact of sleep deprivation on sexual behaviors and FAAH expression in the prefrontal cortex of male rats 2020 ·Neuroscience Letters ·(unknown), Ehsan Saboory, (unknown), Ali Fakhari, Joseph C. Wu, Richard Bruggeman, (unknown), Ali Ahmadalipour	12
12	Multimodal lifestyle intervention using a web-based tool to improve cardiometabolic health in patients with serious mental illness: results of a cluster randomized controlled trial (LION) 2019 ·BMC Psychiatry ·(unknown), Frederike Jörg, Richard Bruggeman, Robert A. Schoevers, Eva Corpeleijn	27
13	Implications of data-driven analyses for personalized therapy in psychosis: a systematic review of cluster- and trajectory-based modelling studies 2019 ·bioRxiv (Cold Spring Harbor Laboratory) ·Tesfa Dejenie Habtewold, (unknown), Edith J. Liemburg, Grigory Sidorenkov, H. Marike Boezen, Richard Bruggeman, Behrooz Z. Alizadeh	2
14	Effects of a lifestyle intervention on psychosocial well-being of severe mentally ill residential patients: ELIPS, a cluster randomized controlled pragmatic trial 2018 ·Schizophrenia Research ·Annemarie Stiekema, (unknown), Lisette van der Meer, Richard Bruggeman, Robert A. Schoevers, Eva Corpeleijn, Frederike Jörg	16
15	Design of the Lifestyle Interventions for severe mentally ill Outpatients in the Netherlands (LION) trial; a cluster randomised controlled study of a multidimensional web tool intervention to improve cardiometabolic health in patients with severe mental illness 2017 ·BMC Psychiatry ·(unknown), Frederike Jörg, Richard Bruggeman, Robert A. Schoevers, Eva Corpeleijn	13
16	[A study of cost-effectiveness of treating serious mental illness: challenges and solutions]. 2016 ·Research Publications (Maastricht University) ·Joran Lokkerbol, (unknown), Silvia Evers, (unknown), Philippe Delespaul, Hans Kroon, Richard Bruggeman	1
17	Overexpression of a DENND1A isoform produces a polycystic ovary syndrome theca phenotype 2014 ·Proceedings of the National Academy of Sciences ·Jan M. McAllister, Bhavi P. Modi, Bruce A. Miller, (unknown), Richard Bruggeman, Richard S. Legro, Jerome F. Strauss	167
18	Natural Medicines in Schizophrenia: A Systematic Review 2014 ·The Journal of Alternative and Complementary Medicine ·Rogier Hoenders, Agna A. Bartels‐Velthuis, (unknown), Richard Bruggeman, (unknown), Joop de Jong	6
19	The Impact of Fish Oil on the Chemopreventive Efficacy of Tamoxifen against Development of N -Methyl- N -Nitrosourea–Induced Rat Mammary Carcinogenesis 2010 ·Cancer Prevention Research ·Andrea Manni, (unknown), Sharlene Washington, César Aliaga, Timothy K. Cooper, John P. Richie, Richard Bruggeman, Bogdan Prokopczyk, Ana Calcagnotto, Neil Trushin, David T. Mauger, Michael F. Verderame, Karam El‐Bayoumy	29
20	Sexual dysfunctions in patients using risperidone or olanzapine: A randomised trial 2001 ·Data Archiving and Networked Services (DANS) ·Rikus Knegtering, (unknown), Durk Wiersma, Richard Bruggeman, (unknown), (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact